2019 Exhibitor List

On Line Exhibitor Services Kit


 

Cancellation Policy

  • Refund less 10% of exhibit fee if cancelled by September 3, 2019.
  • Refund less 75% of exhibit fee if cancelled by September 30, 2019.
  • Positively no refund for cancellations thereafter.

2019 SABCS Exhibitors


Name Booth Number
Agendia, Inc 320 
Alamo Breast Cancer Foundation
526
Ambry Genetics, A Konica Minolta Company 630
American Association for Cancer Research
922
Amgen, Inc
431 & 530
AstraZeneca 901
Athenex Oncology  627 
Breast Cancer Art Exhibit 327 
Biotheranostics, Inc
413
BRAVE Coalition Foundation
223
Breast Cancer Action
916
Bristol-Myers Squibb   529 
Caris Life Sciences 421
Celgene Corporation
520
Cianna Medical/Merit Medical    631
Coherus BioSciences 914
Daiichi Sankyo, Inc. 507 & 635
Dan L. Duncan Comprehensive Cancer Center @ Baylor College of Medicine
707 
Datar Cancer Genetics Limited
129 
Dignitana 318
Eisai, Inc
701
Elsevier  T8
Elucent  Medical, Inc 127
Encore Medical Education, LLC. 213 
Epic Sciences 626
ESMO - European Society For Medical Oncology  429 
Genentech, A Member of the Roche Group 601
Genomic Health
301
Global Breast Cancer Conference  727 
Harborside  T2 
HealthCare Partners Nevada 1009 
Hologic, Inc  609 
The IBC Network Foundation 808
Immunomedics, Inc 721
Integrated Oncology  810 
Invicro  830 
Invitae T10 
JAMA Network 715
Jeunesse Innovations  T5
Lilly Oncology
801 & 1006
Lumicell, Inc
221
MacroGenics, Inc
313
Male Breast Cancer Coalition
907
Med-Care Pharmaceuticals  T4 
Medscape Oncology 1003 
Menarini Silicon Biosystems  909 
Merck & Co., Inc
307 & 527
METAvivor Research and Support, Inc
T7
MpBC Global Alliance, Inc T1
Mylan Inc 227 
Myriad Genetic Laboratories, Inc. 113
NanoString Technologies
807
NeoGenomics 717
Novartis Oncology
501 & 614
OBI Pharma USA, Inc 1001 
The Oncologist 531
Paxman USA Inc 706
 Pfizer
729
Pfizer Oncology Medical 407
Pfizer Oncology - Ibrance & Talzenna
401
Philips Molecular Pathway DX
806
Physician's Education Resource, LLC T6
PreludeDx 728
Puma Biotechnology, Inc. 521
Radius Health, Inc.  119
Roche Diagnostics Corporation 607
R-Pharm US  710
Research To Practice 826 
Seattle Genetics 730 & 814
Sema4 720 
Sermonix Pharmaceuticals T9 
Sibliotech, Inc.  708
Society of Surgical Oncology 427 
Spectrum Pharmaceuticals 621
Stayhealthy Inc. 232 
Syndax Pharmaceuticals 1005
Tactile Medical T11 
Tempus  711
TerSera Therapeutics   726
TRIO - Translational Research in Oncology 219
TxSCO - Texas Society of Clinical Oncology T12 
UT MD Anderson Cancer Center  226
VISION RT  T3 
Wolters Kluwer
133
Zeiss 828 
 Zero Gravity 611

Product Theatre Schedule

Product Theatre - Exhibit Hall 2

 

 

Wednesday, December 11  12:30 pm

Integrating Clinical-Pathologic Features with the Recurrence Score® Result to Help Guide Adjuvant Treatment Decisions
presented by Genomic Health, Inc

Wednesday, December 11 2:00 pm
HER2-Positive Early Breast Cancer: Optimizing adjuvant treatement based on response to neoadjuvant therapy 
presented by Genentech, A Member of the Roche Group

 

Thursday, December 12 11:00 am
New Survival Data for a Treatment Option Approved for Patients With HR+, HER2- Metastatic Breast Cancer 
© Lilly USA, LLC 2019. All rights reserved.
presented by Lilly Oncology


Thursday, December 12  12:30 pm 
Innovative Oral Treatment Options for Patients: HR+/HER2- MBC or gBRCA-Mutated TNBC and HR+/HER2- MBC  
presented by Pfizer Oncology

Thursday, December 12  2:00 pm 
  Lynparza: An Optimal Targeted Treatment for gBRCAm HER2-Negative Metastatic Breast Cancer

presented by AstraZeneca

Thursday, December 12  3:30 pm
Advancing the Treatment of TECENTRIQ, the first cancer immunotherapy approved for the treatment of PD-L1 mTNBC
presented by Genentech, A Member of the Roche Group

Friday, December 13 11:00 am
Innovative Biomarker Strategies for Translational Medicine and Clinical Practice in Breast Cancer.
presented by NanoString Technologies

Friday, December 13 12:30 pm
The ONLY Endocrine Biomarker: Presenting New Pivotal Data from the Translational aTTom 
presented by Biotheranostics, Inc

Friday, December 13  2:00 pm
Two Considerations in HR+/HER2- mBC: The Importance of PIK3CA Mutations and the Arrival of OS Data With a CDK4/6 Inhibitor
presented by Novartis Oncology


Demographics

2018 San Antonio Breast Cancer Symposium there were 7,066 Symposium attendees + 129 Media + 554 Exhibitors, Non-Exhibiting Sponsors & their Support Staff = 7,749 total attendance.

49% came from 88 countries outside the USA.  Click here to view an audited 2018 SABCS registration report, which includes further details.


Lead Retrieval


Code of Conduct

Exhibitors agree to adhere to the compliance guidelines and codes of conduct governing the interactions of drug and device manufacturers with healthcare professionals as promulgated by the U.S. Food and Drug Administration, the Department of Health and Human Services Office of the Inspector General, the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Advanced Medical Technology Association AdvaMed.


Rules

  • Display elements and fixtures cannot exceed a height of ten feet (10’). This rule pertains to both in-line and island displays. 
  • An individual exhibit cannot straddle an aisle.
  • No microphones or vocal amplification may be used at any time. 
  • Unstaffed exhibits are not permitted.
  • Sharing of booth space with an unrelated company is not permitted. 
  • “Subleasing” of booth space to an unrelated company is not permitted.
  • Table exhibits: exhibit fixtures and product are limited to the table top only. 
  • All ladders & related equipment must be removed from the building following move-in. 
  • Departure and/or removal of exhibit prior to end of show will affect placement in subsequent years and may result in exhibitor being
    barred from exhibiting in the future.

Exhibit Schedule

Hours may be subject to change.

Monday, December 9 – Exhibit move-in 
20’x20’, 10’x30’ and 10’x40’
Noon – 6:00 PM
Tuesday, December 10 – Exhibit move-in
All exhibits
8:00 AM – 6:00 PM
Wednesday, December 11 – Detailing only
All exhibits
9:00 AM – 11:00 AM
Exhibits open
Wednesday, December 11
10:45 AM – 5:00 PM
Thursday, December 12
10:45 AM – 5:00 PM
Friday, December 13
10:45 AM – 5:00 PM
Friday, December 13 – Exhibit move-out
Preliminary dismantle
5:00 PM – 5:30 PM
Return of empty cartons & cases, materials pack-up
5:30 PM – 6:00 PM
Full move-out
6:00 PM – 11:00 PM
Exhibitor Registration Hours
Monday, December 9
8:00 AM - 5:00 PM
Tuesday, December 10
8:00 AM - 7:00 PM
Wednesday, December 11
7:00 AM - 5:15 PM
Thursday, December 12
6:45 AM - 5:15 PM
Friday, December 13
6:45 AM - 4:00 PM



Exhibitor Registration

Complimentary exhibit area only registrations entitle the registrant to access the registration area and the exhibit area only, including off-hours access to exhibit area. Full registration is required in order to attend SABCS programs. 

In collaboration with  Astro     and     SSO